openPR Logo
Press release

Cox 2 Inhibitors Market Promising Growth Opportunities over 2018-2026(Segmentation by Indication Osteoarthritis Rheumatoid Arthritis Menstrual Cramps Sports Injuries Others)

06-06-2019 08:55 AM CET | Health & Medicine

Press release from: Fact.MR

/ PR Agency: Fact.MR
Cox 2 Inhibitors Market Promising Growth Opportunities over

Cox 2 Inhibitors are a type of non-steroidal anti-inflammatory drugs. These drugs are responsible for decreasing the production of prostaglandins.

These drugs also reduce the production of chemicals that play an important role in promoting fever, inflammatory pain etc. Cyclooxygenase (Cox) is an enzyme, which is responsible for producing prostaglandins. The cyclooxygenase enzymes are of two types- cox 1 and cox 2. Cox 2 inhibitors, reduce the production of prostaglandins, hence, can reduce inflammatory pain, fever etc.

There are some of the safety issues, associated with cox 2 inhibitors, hence, they have been taken off from the U.S. market.

Also, many products have been recalled in the market. For example- Vioxx, which is a cox 2 inhibitor, was recalled worldwide in 2004 as it caused cardiovascular diseases such as heart attacks and heart strokes. Bextra, which is another cox 2 inhibitor, was taken off from many European and U.S. markets in April 2005 due to cardiovascular risks and life-threatening skin reactions. There are many such other products like Prexige, which was withdrawn from most of the world’s market because of the severe liver damage caused by this drug. There are many controversies ongoing, which are criticizing the use of cox 2 inhibitors.

Celecoxib is the only COX-2 inhibitor, which is currently available in the United States. There is a new approach to manufacturing natural Cox 2 inhibitors, which is being adopted by the company, Sabinsa. Manufacture of natural Cox 2 inhibitors have very fewer side effects and is expected to be highly adopted by the people.

Request Free Sample Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=3221

The high adoption rate of cox 2 inhibitors, such as aspirin pain killer, is one of the major factors, driving the growth of cox 2 inhibitors market. The increasing prevalence of chronic diseases, such as rheumatoid arthritis, osteoarthritis, and other diseases, is expected to increase the growth of cox 2 inhibitors market. Increasing awareness of physical activities can lead to sports injury, which can also be expected to drive the cox 2 inhibitors market.

The cox 2 inhibitors have many safety issues, hence, some of the cox 2 inhibitors have been withdrawn from the U.S. market. For example- Arcoxia is a cox 2 inhibitor, which is present in many countries but not in U.S. Dynastat is another cox 2 inhibitors, which is a form of injectable medicine and is not available in the U.S. market. The safety issues, associated with cox 2 inhibitors, can restrain the growth of cox 2 inhibitors market. Intake of cox 2 inhibitors, can also cause gastrointestinal problems for the people, which decreases the demand of ox 2 inhibitors, hence, can hamper the growth of the overall market. Other side effects, such as headache, migraine, nausea, also decreases the demand for cox 2 inhibitors.

The global Cox 2 Inhibitors market is segmented on the basis of product type, Indication, distribution channel, and geography:

Segmentation by Product type
Selective Cox 2 Inhibitors
Non Selective Cox 2 Inhibitors
Segmentation by Indication
Osteoarthritis
Rheumatoid Arthritis
Menstrual Cramps
Sports Injuries
Others
Segmentation by distribution channels
Hospital Pharmacies
Drug stores
Retail pharmacies
Based on the product type, the Cox 2 Inhibitors are segmented into selective cox 2 inhibitors and non- selective cox 2 inhibitors. Selective Cox 2 inhibitors are generally used for the treatment of osteoarthritis and rheumatoid arthritis. Selective Cox 2 inhibitors are expected to hold the largest revenue share in Cox 2 Inhibitors market. Non Selective Cox 2 inhibitors include drugs such as aspirin, ibuprofen etc. Basically, Cox 2 inhibitors are used to treat inflammatory pain. Based on the indication, the Cox 2 inhibitors market has been segmented into indication such as osteoarthritis, rheumatoid arthritis, menstrual cramps etc. Based on the end user, the market has been segmented into hospital pharmacies, drug stores, retail pharmacies. Drug stores are expected to show the maximum sales of Cox 2 inhibitors and can hold a large revenue share in the market.

Request/View TOC@ https://www.factmr.com/connectus/sample?flag=T&rep_id=3221

Geographically, global Cox 2 Inhibitors market has been divided into few regions, such as North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. North America is expected to dominate the cox 2 inhibitors global market due to the presence of high research and developmental activities. Europe is expected to hold the second largest share in the global Cox 2 Inhibitors market due to the presence of high population and high prevalence of rheumatoid arthritis. The Asia Pacific is expected to hold a large share in the cox 2 inhibitors market because of the presence of more number of people preferring inflammatory pan medicines.

There are only a few companies, such as Cadila Pharmaceuticals, which are manufacturing cox 2 inhibitors. Sabinsa manufactures natural herbal drugs and is focusing on manufacturing natural Cox 2 inhibitors.

The report covers exhaustive analysis on:

Cox 2 Inhibitors Market Segments
Cox 2 Inhibitors Market Dynamics
Historical Actual Market Size, 2013 - 2015
Cox 2 Inhibitors Market Size & Forecast 2016 to 2024
Cox 2 Inhibitors Agents Current Trends/Issues/Challenges
Competition & Companies involved
Cox 2 Inhibitors Market Drivers and Restraints
Regional analysis includes:

North America
Latin America
Europe
Asia Pacific
Middle East & Africa
Report Highlights:

Shifting Industry dynamics
In-depth market segmentation
Historical, current and projected industry size Recent industry trends
Key Competition landscape
Strategies for key players and product offerings
Potential and niche segments/regions exhibiting promising growth
A neutral perspective towards market performance

Report Analysis@ https://www.factmr.com/report/3221/cox-2-inhibitors-market

Contact Us
Rohit Bhisey
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/

About US
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cox 2 Inhibitors Market Promising Growth Opportunities over 2018-2026(Segmentation by Indication Osteoarthritis Rheumatoid Arthritis Menstrual Cramps Sports Injuries Others) here

News-ID: 1766132 • Views:

More Releases from Fact.MR

Non-Alcoholic Wine Market to Expand at 10% CAGR, Reaching $5.2 Billion by 2033
04-19-2024 | Food & Beverage
Fact.MR
Non-Alcoholic Wine Market to Expand at 10% CAGR, Reaching $5.2 Billion by 2033
The global demand for non-alcoholic wine is predicted to grow at a 10% CAGR between 2023 and 2033. The global non-alcoholic wine market is currently valued at $2 billion and is expected to grow to $5.2 billion by 2033. Increased demand for nonalcoholic wine in Middle Eastern nations like Kuwait and the UAE will drive market expansion. Athletes and pregnant women are the primary consumers of non-alcoholic wine. The health ramifications
Personal Floatation Devices Market Soars, Expected to Hit US$ 8,014 Million by 2032
04-19-2024 | Sports
Fact.MR
Personal Floatation Devices Market Soars, Expected to Hit US$ 8,014 Million by 2 …
The global personal floatation devices market is expected to be valued at US$ 3,178.7 million in 2022, growing at a CAGR of 9.7% to US$ 8,014 million by the end of 2032. The personal flotation device market is transitioning from 'distributor-based' sales to direct-to-customer online channels. Catering to the needs of last-mile consumers is a profitable opportunity for manufacturers, and utilising online sales channels can help businesses capitalise on the emerging
Paper Bottle Market Expected to Expand at 6.2% CAGR by 2033
Paper Bottle Market Expected to Expand at 6.2% CAGR by 2033
The Paper Bottles Market is estimated to reach US $ 53.31 million by 2033, with a 6.2% growth rate during the forecast period. Paper bottle sales are fast increasing, owing to both the growing need for alternatives to plastic bottles and the degradability and eco-friendliness of these containers. Paper bottle sales are expected to rise as demand for beverages rises and effective storage becomes more important. Get Free Sample Copy of This
Halloumi Cheese Market Surges Past US$ 1.2 Billion Mark by 2033, Fueled by 10.4% CAGR
04-19-2024 | Food & Beverage
Fact.MR
Halloumi Cheese Market Surges Past US$ 1.2 Billion Mark by 2033, Fueled by 10.4% …
It is anticipated that halloumi cheese market will be valued at US$ 445 million in 2023 and surpass US$ 1.2 billion by the end of 2033. It is projected that the worldwide market for halloumi cheese will grow at an astounding rate of 10.4% CAGR till 2033. Cyprus, a Middle Eastern nation, is the birthplace of halloumi cheese, which has been made there by local farmers for generations. Since this nation

All 5 Releases


More Releases for Cox

Outbound Tourism Market Worth Observing Growth : NSO, Cox & Kings, Visitcopenhag …
COVID-19 Outbreak-Global Outbound Tourism Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020 is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the COVID-19 Outbreak-Global Outbound Tourism Market. Some of the key players profiled
“Blob and the Elephant” by Rupert Stewart Cox is published
ISBN #979-8648350793 “Blob and the Elephant” by Rupert Stewart Cox is published First book in “The Adventures of a Creature Called Blob” About the Book: There are two types of elephant that Blob could fly to see, African and Asian, which one would it be, African elephants are bigger and have enormous ears. The oldest ones can live for nearly a hundred years. The first in a series of picture book stories about a
Cox-2 Inhibitors Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Cox-2 Inhibitors Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 102 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/global-cox-2-inhibitors-market_p108144.html   Cox-2 Inhibitors are a type of nonsteroidal anti-inflammatory
Cox 2 Inhibitors Market In-Depth Market Research Report 2018-2026(Segmentation b …
Cox 2 Inhibitors are a type of non-steroidal anti-inflammatory drugs. These drugs are responsible for decreasing the production of prostaglandins. These drugs also reduce the production of chemicals that play an important role in promoting fever, inflammatory pain etc. Cyclooxygenase (Cox) is an enzyme, which is responsible for producing prostaglandins. The cyclooxygenase enzymes are of two types- cox 1 and cox 2. Cox 2 inhibitors, reduce the production of prostaglandins, hence,
Travel Services Market Is Booming Worldwide | Cox & Kings, MakeMyTrip, Yatra
HTF MI recently introduced India 2017-2021 Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are Cox & Kings, MakeMyTrip, SOTC, Thomas Cook, Yatra, Airbnb, Busindia.com, Cleartrip, Expedia,
Electronic Cleaning Market: ITW, Electrolube, ZESTRON, 3M, Cox Industries
HTF MI published a new industry research that focuses on Electronic Cleaning market and delivers in-depth market analysis and future prospects of Global Electronic Cleaning market. The study covers significant data which makes the research document a handy resource for managers, analysts, industry experts and other key people get ready-to-access and self-analyzed study along with graphs and tables to help understand market trends, drivers and market challenges. The study is